Sale of Flow Cytometry and Imaging Business From DiaSorin to Cytek® Biosciences Completed
28 févr. 2023 09h21 HE
|
Cytek Biosciences, Inc.
SALUGGIA, Italy, and FREMONT, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- DiaSorin (FTSE MIB: DIA) and Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that Luminex Corporation, a wholly...
Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin
13 févr. 2023 16h07 HE
|
Cytek Biosciences, Inc.
Sale of assets related to Flow Cytometry & Imaging (FCI) Business UnitAcquisition will expand Cytek’s product portfolio to include imaging and menu-based application driven flow cytometry to...